At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 5
- ✓Singleton pregnancy (one fetus)
- ✓Gestational age greater than 27 weeks
- ✓Intact amniotic membranes
- ✓Normal umbilical cord anatomy (two arteries and one vein)
Key exclusion· 5
- ✕Any fetal congenital anomalies
- ✕Multiple pregnancy (multifetal gestation)
- ✕Maternal chronic diseases including hypertension, renal disease, cardiac or pulmonary disease
- ✕Oligohydramnios, pre-eclampsia, or intrauterine growth retardation
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Role of Umbilical Cord Thickness, Interventricular Septum Thickness and HbA1C Levels in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus
In Brief
An observational study for Gestational Diabetes. Completed, enrolled 80 participants.
Detailed Summary
The aim of this work is the prediction of fetal macrosomia by measuring: 1. HbA1C. 2. Umbilical cord thickness. 3. Interventricular septum thickness.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGestational Diabetes
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartApr 2015
Primary CompletionOct 2015
Study CompletionNov 2015
First PostedDec 2015
TodayJul 2026
First PostedDec 31, 2015
Enrollment StartApr 1, 2015
Primary CompletionOct 1, 2015
Study CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.5 years ago